Dr Anji Anand

Consultant Clinical Oncologist



Radiotherapy, Chemotherapy, Hormonal Therapy, Biological Therapy

Current NHS Post

Nottingham City Hospital

Year Qualified


Clinical Interests

Cervical cancer, concurrent chemo-radiotherapy, HDR brachytherapy, uterine cancers, Intensity modulated radiotherapy, ovarian cancers, adjuvant and palliative chemotherapy, VEGF inhibitors, PARP inhibitors, adjuvant breast radiotherapy, advanced breast cancers, palliative chemotherapy for breast cancers, palliative radiotherapy for pain control, endocrine treatment for breast cancers, monoclonal antibody treatment

Research Interests

Ovarian Cancer, Breast Radiotherapy

Professional Memberships

  • Fellow of the Royal College of Radiologists
  • European Society of Gynaecological Oncology
  • European Society of Radiology and Oncology


Dr Anji Anand is currently working as a Consultant Clinical Oncologist at Nottingham University Hospitals NHS trust. She has been in this post since 2010. Prior to her appointment as a consultant she trained as specialist registrar at Nottingham University Hospitals, Derby Royal Infirmary and University Hospitals of Leicester. Her special interests are gynaecological cancers and breast cancers. She is the Lead Clinician instrumental in the development of HDR intracavitary brachytherapy for cervical and uterine cancers. In addition, she also treats ovarian cancer and has a special interest in the use of PARP inhibitors. She also treats patients with breast cancer using appropriate modalities of treatment- chemotherapy, adjuvant and palliative radiotherapy and endocrine treatment.

Book an appointment